Deferred Maintenance: Cash, Muscle, Sleep

The four biggest tech companies are planning as much as $725 billion of capital spending this year — up 77% in a single year — much of it on machines that never have to sleep. The people underwriting that bet will not get eight hours themselves.

Meanwhile, three much smaller accounts are quietly compounding, or quietly rotting, inside every one of us. This episode is about cash, muscle, and sleep — why they're the three things that actually decide how the next thirty years go, why only one of them behaves the way you assume it does, and why the toolkit you already use on your portfolio is the right one to point at them.

In this episode:

One compounds. One depreciates. One is the bill.Most advice treats these three as the same kind of asset. They aren't. Wealth compounds — left alone and sensibly invested, it makes more of itself, and it's the only one of the three that does. Muscle depreciates: a capital asset with an upkeep bill. And sleep isn't an asset at all. Sleep is the maintenance capex — the spend you can defer while looking absolutely fine, right up until the asset base rots underneath you.

The barnacles on your bank statement.Zuora's Subscription Economy Index started at 100 in January 2012 and reached 437 by early 2021 — more than quadrupling in under a decade. (It's built from Zuora's own customers, and Zuora sells subscription billing, so treat it like any vendor's chart.) A subscription is a beautiful asset — if you're the one collecting it. Homework: open your bank statement and read every recurring charge line by line. And the number that should focus the mind: reach 65 and a U.S. man has roughly 18 more years to fund, a woman closer to 21.

"Strength, But Not Muscle Mass, Is Associated With Mortality."That's a real paper title. 2,292 Americans in their seventies, followed five years, strength measured and actual muscle measured by CT and DXA. Strength predicted who died. Size didn't. Also: the 1–2%-a-year muscle-loss figure quoted everywhere is flagged as misattributed in the peer-reviewed literature — the real number is under 1%. You're probably already eating enough protein; the target may just be in the wrong place. And the account never closes — in one study, 12 months of resistance training in men around 70 added 12% calf volume and 20% torque.

You feel basically fine. You are not fine.Six hours in bed for fourteen straight nights produced attention deficits equivalent to up to two full nights without sleep. The participants did notice they were tired. What they didn't notice was how much worse they'd got — subjective sleepiness rose gently while performance fell off a cliff. That gap is the entire problem. Also inside: what the daylight-saving data does and doesn't prove, and the episode walking back its own inference on air.

"This is wellness content in a finance costume."The bear case, stated fairly. Plus the harder objection: this episode calls night-shift work probably carcinogenic and then tells you to control your inputs. The people most exposed are the ones who can't. A nurse on rotating nights doesn't need blackout curtains — she needs a different roster. These accounts are controllable at the margin, and the margin is far wider for some than others.

What it means for you:The loudest number in this market is $725 billion chasing a machine that never sleeps. The quietest is whatever happened last night in three accounts that never show up on any tape. All three are invisible when they're working. All three punish the person who mistakes a slow signal for no signal. The hard part was never knowing what to do — it's being the kind of patient a slow-feedback system rewards. In a portfolio, and in a life.

New episodes weekly. Subscribe on Apple Podcasts, Spotify, YouTube, or Amazon Music.

Conviction Bet is independent investment commentary. Nothing in this episode is investment advice.